Icecure Medical LTD Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
A significant shareholder's director, Mr. Li Haixiang, has resigned from the board of IceCure Medical Ltd., while the reporting persons maintain a 45.8% beneficial ownership stake.
NASDAQ
SCHEDULE 13D: Major Shareholder Li Haixiang and Epoch Partner Investments Disclose 45.7% Stake in IceCure Medical Ltd.
Li Haixiang and Epoch Partner Investments Limited have disclosed a significant beneficial ownership of 45.7% in IceCure Medical Ltd., holding 25,846,597 ordinary shares for investment purposes.